128 related articles for article (PubMed ID: 23461859)
41. Chitosan is a surprising negative modulator of cytotoxic CD8+ T cell responses elicited by adenovirus cancer vaccines.
Lemke CD; Graham JB; Geary SM; Zamba G; Lubaroff DM; Salem AK
Mol Pharm; 2011 Oct; 8(5):1652-61. PubMed ID: 21780831
[TBL] [Abstract][Full Text] [Related]
42. Lipid peroxidation causes endosomal antigen release for cross-presentation.
Dingjan I; Verboogen DR; Paardekooper LM; Revelo NH; Sittig SP; Visser LJ; Mollard GF; Henriet SS; Figdor CG; Ter Beest M; van den Bogaart G
Sci Rep; 2016 Feb; 6():22064. PubMed ID: 26907999
[TBL] [Abstract][Full Text] [Related]
43. Photochemical Internalization Enhanced Vaccination Is Safe, and Gives Promising Cellular Immune Responses to an HPV Peptide-Based Vaccine in a Phase I Clinical Study in Healthy Volunteers.
Otterhaug T; Janetzki S; Welters MJP; Håkerud M; Nedberg AG; Edwards VT; Boekestijn S; Loof NM; Selbo PK; Olivecrona H; van der Burg SH; Høgset A
Front Immunol; 2020; 11():576756. PubMed ID: 33488576
[TBL] [Abstract][Full Text] [Related]
44. Cyclophosphamide induces bone marrow to yield higher numbers of precursor dendritic cells in vitro capable of functional antigen presentation to T cells in vivo.
Salem ML; El-Naggar SA; Cole DJ
Cell Immunol; 2010; 261(2):134-43. PubMed ID: 20036354
[TBL] [Abstract][Full Text] [Related]
45. MHC class I endosomal and lysosomal trafficking coincides with exogenous antigen loading in dendritic cells.
Basha G; Lizée G; Reinicke AT; Seipp RP; Omilusik KD; Jefferies WA
PLoS One; 2008 Sep; 3(9):e3247. PubMed ID: 18802471
[TBL] [Abstract][Full Text] [Related]
46. Heat shock protein magic in antigen trafficking within dendritic cells: implications in antigen cross-presentation in immunity.
Udono H
Acta Med Okayama; 2012; 66(1):1-6. PubMed ID: 22358133
[TBL] [Abstract][Full Text] [Related]
47. Effects of mizoribine on MHC-restricted exogenous antigen presentation in dendritic cells.
Song Y; Han S; Kim H; Kim K; Kwon J; Lee SJ; Ha NJ; Lee YH; Lee CK; Kim K
Arch Pharm Res; 2006 Dec; 29(12):1147-53. PubMed ID: 17225465
[TBL] [Abstract][Full Text] [Related]
48. Intracellular targeting specificity of novel phthalocyanines assessed in a host-parasite model for developing potential photodynamic medicine.
Dutta S; Ongarora BG; Li H; Vicente Mda G; Kolli BK; Chang KP
PLoS One; 2011; 6(6):e20786. PubMed ID: 21673971
[TBL] [Abstract][Full Text] [Related]
49. Heat shock protein 90 mediates efficient antigen cross presentation through the scavenger receptor expressed by endothelial cells-I.
Murshid A; Gong J; Calderwood SK
J Immunol; 2010 Sep; 185(5):2903-17. PubMed ID: 20686127
[TBL] [Abstract][Full Text] [Related]
50. Prolonged antigen survival and cytosolic export in cross-presenting human gammadelta T cells.
Meuter S; Eberl M; Moser B
Proc Natl Acad Sci U S A; 2010 May; 107(19):8730-5. PubMed ID: 20413723
[TBL] [Abstract][Full Text] [Related]
51. Photochemical internalisation: a novel drug delivery system.
Selbo PK; Høgset A; Prasmickaite L; Berg K
Tumour Biol; 2002; 23(2):103-12. PubMed ID: 12065848
[TBL] [Abstract][Full Text] [Related]
52. Photochemical internalisation, a minimally invasive strategy for light-controlled endosomal escape of cancer stem cell-targeting therapeutics.
Selbo PK; Bostad M; Olsen CE; Edwards VT; Høgset A; Weyergang A; Berg K
Photochem Photobiol Sci; 2015 Aug; 14(8):1433-50. PubMed ID: 25805311
[TBL] [Abstract][Full Text] [Related]
53. Topical vaccination with functionalized particles targeting dendritic cells.
Baleeiro RB; Wiesmüller KH; Reiter Y; Baude B; Dähne L; Patzelt A; Lademann J; Barbuto JA; Walden P
J Invest Dermatol; 2013 Aug; 133(8):1933-41. PubMed ID: 23426134
[TBL] [Abstract][Full Text] [Related]
54. Kinesin-1 regulates antigen cross-presentation through the scission of tubulations from early endosomes in dendritic cells.
Belabed M; Mauvais FX; Maschalidi S; Kurowska M; Goudin N; Huang JD; Fischer A; de Saint Basile G; van Endert P; Sepulveda FE; Ménasché G
Nat Commun; 2020 Apr; 11(1):1817. PubMed ID: 32286311
[TBL] [Abstract][Full Text] [Related]
55. Aptamer-targeted antigen delivery.
Wengerter BC; Katakowski JA; Rosenberg JM; Park CG; Almo SC; Palliser D; Levy M
Mol Ther; 2014 Jul; 22(7):1375-1387. PubMed ID: 24682172
[TBL] [Abstract][Full Text] [Related]
56. Exosomal cancer immunotherapy is independent of MHC molecules on exosomes.
Hiltbrunner S; Larssen P; Eldh M; Martinez-Bravo MJ; Wagner AK; Karlsson MC; Gabrielsson S
Oncotarget; 2016 Jun; 7(25):38707-38717. PubMed ID: 27231849
[TBL] [Abstract][Full Text] [Related]
57. Immature human DCs efficiently translocate endocytosed antigens into the cytosol for proteasomal processing.
Baleeiro RB; Walden P
Mol Immunol; 2017 Aug; 88():148-154. PubMed ID: 28644974
[TBL] [Abstract][Full Text] [Related]
58. Enhanced antigen presentation and immunostimulation of dendritic cells using acid-degradable cationic nanoparticles.
Kwon YJ; Standley SM; Goh SL; Fréchet JM
J Control Release; 2005 Jul; 105(3):199-212. PubMed ID: 15935507
[TBL] [Abstract][Full Text] [Related]
59. Mannose-functionalized antigen nanoparticles for targeted dendritic cells, accelerated endosomal escape and enhanced MHC-I antigen presentation.
Pei M; Xu R; Zhang C; Wang X; Li C; Hu Y
Colloids Surf B Biointerfaces; 2021 Jan; 197():111378. PubMed ID: 33010719
[TBL] [Abstract][Full Text] [Related]
60. The translocon protein Sec61 mediates antigen transport from endosomes in the cytosol for cross-presentation to CD8(+) T cells.
Zehner M; Marschall AL; Bos E; Schloetel JG; Kreer C; Fehrenschild D; Limmer A; Ossendorp F; Lang T; Koster AJ; Dübel S; Burgdorf S
Immunity; 2015 May; 42(5):850-63. PubMed ID: 25979419
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
